Lab tests to predict outcomes in sepsis patients
Part of Infections clinical trials.
This study looks at whether certain blood test results can help predict how well people with sepsis will do. Sepsis is a serious infection that can affect the whole body. You may be able to join if you have sepsis and are over 18.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with sepsis, a severe infection that affects your whole body.
- You must be 18 years old or older.
- You cannot have a blood disorder like leukemia or lymphoma.
- You must be willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
This trial tests a new blood test called the Sepsis ImmunoScore that may help doctors quickly identify sepsis (a life-threatening infection response). The test looks at your immune system's response to see if you have sepsis, which could help you get treatment faster.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This trial checks if certain blood markers (CRP, CRP/albumin ratio, and neutrophil/lymphocyte ratio) can predict how well sepsis patients with normal blood pressure will do. It aims to help doctors better manage infections and survival.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.